TW200500376A - Novel adenosine analogues and their use as pharmaceutical agents - Google Patents

Novel adenosine analogues and their use as pharmaceutical agents

Info

Publication number
TW200500376A
TW200500376A TW092117351A TW92117351A TW200500376A TW 200500376 A TW200500376 A TW 200500376A TW 092117351 A TW092117351 A TW 092117351A TW 92117351 A TW92117351 A TW 92117351A TW 200500376 A TW200500376 A TW 200500376A
Authority
TW
Taiwan
Prior art keywords
pharmaceutical agents
adenosine analogues
novel adenosine
novel
compounds
Prior art date
Application number
TW092117351A
Other languages
English (en)
Chinese (zh)
Inventor
Antony Bigot
Siegfried Stengelin
Gerhard Jahne
Andreas Herling
Gunter Muller
Jakob Hock Franz
R Myers Michael
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of TW200500376A publication Critical patent/TW200500376A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TW092117351A 2002-06-27 2003-06-26 Novel adenosine analogues and their use as pharmaceutical agents TW200500376A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02014324A EP1375508A1 (fr) 2002-06-27 2002-06-27 Dérivés de l'adénosine N6-substitués et leur utilisation comme médicament

Publications (1)

Publication Number Publication Date
TW200500376A true TW200500376A (en) 2005-01-01

Family

ID=29716849

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092117351A TW200500376A (en) 2002-06-27 2003-06-26 Novel adenosine analogues and their use as pharmaceutical agents

Country Status (19)

Country Link
EP (2) EP1375508A1 (fr)
JP (1) JP2006501178A (fr)
KR (1) KR20050014888A (fr)
CN (1) CN1671728A (fr)
AR (1) AR039697A1 (fr)
AU (1) AU2003280141A1 (fr)
BR (1) BR0312428A (fr)
CA (1) CA2490253A1 (fr)
HR (1) HRP20041209A2 (fr)
IL (1) IL165934A0 (fr)
MA (1) MA27465A1 (fr)
MX (1) MXPA04012815A (fr)
NO (1) NO20050398L (fr)
PE (1) PE20040584A1 (fr)
PL (1) PL375197A1 (fr)
RU (1) RU2005101872A (fr)
TW (1) TW200500376A (fr)
WO (1) WO2004003002A1 (fr)
ZA (1) ZA200410062B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006293618B9 (en) 2005-09-21 2009-10-29 Pfizer Limited Carboxamide derivatives as muscarinic receptor antagonists
JP2007153789A (ja) * 2005-12-05 2007-06-21 Mitsui Chemicals Inc 光学活性３−アミノピロリジン誘導体の製造方法
EP2025674A1 (fr) 2007-08-15 2009-02-18 sanofi-aventis Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
EP2567959B1 (fr) 2011-09-12 2014-04-16 Sanofi Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
CN119039201A (zh) * 2024-07-19 2024-11-29 苏州汉德创宏生化科技有限公司 一种(s)-1-叔丁氧羰基-3-氨基吡咯烷的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545645A1 (de) * 1965-12-06 1969-08-21 Boehringer Mannheim Gmbh Verfahren zur Herstellung von disubstituierten Adenosin-Derivaten
AU575438B2 (en) * 1984-10-26 1988-07-28 Warner-Lambert Company N6 - substituted deoxyribose analogues of adenosines
US4755594A (en) * 1986-01-31 1988-07-05 Warner-Lambert Company N6 -substituted adenosines
AU8276187A (en) * 1986-10-31 1988-05-25 Warner-Lambert Company Selected n6-substituted adenosines having selective a2 binding activity
WO1997033591A1 (fr) * 1996-03-13 1997-09-18 Novo Nordisk A/S Procede de traitement d'affections associees aux cytokines chez les mammiferes
US6376472B1 (en) * 1996-07-08 2002-04-23 Aventis Pharmaceuticals, Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
UA51716C2 (uk) * 1996-07-08 2002-12-16 Авентіс Фармасьютікалз Продактс Інк. Сполуки, що мають гіпотензивну, кардіопротекторну, анти-ішемічну та антиліполітичну властивості, фармацевтична композиція та способи лікування
WO1998052611A1 (fr) * 1997-05-23 1998-11-26 Nippon Shinyaku Co., Ltd. Preparation medicamenteuse aux fins de la prevention et du traitement des hepatopathies
GB9723589D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
GB9723566D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
PE20040584A1 (es) 2004-11-03
MA27465A1 (fr) 2005-08-01
HRP20041209A2 (en) 2005-08-31
JP2006501178A (ja) 2006-01-12
WO2004003002A1 (fr) 2004-01-08
AR039697A1 (es) 2005-03-09
MXPA04012815A (es) 2005-02-24
ZA200410062B (en) 2008-08-27
BR0312428A (pt) 2005-04-26
EP1375508A1 (fr) 2004-01-02
EP1527083A1 (fr) 2005-05-04
RU2005101872A (ru) 2005-08-10
AU2003280141A1 (en) 2004-01-19
IL165934A0 (en) 2006-01-15
CA2490253A1 (fr) 2004-01-08
PL375197A1 (en) 2005-11-28
KR20050014888A (ko) 2005-02-07
NO20050398L (no) 2005-01-25
CN1671728A (zh) 2005-09-21

Similar Documents

Publication Publication Date Title
SE0102299D0 (sv) Compounds
SE0102300D0 (sv) Compounds
SE0001899D0 (sv) New compounds
CY1115484T1 (el) Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
IL173203A0 (en) Novel cyano thiazolides, methods for the production thereof, and use thereof as a medicament
GEP20125565B (en) Lactam compounds and their pharmaceutical use
MXPA04001500A (es) Compuestos que tienen un efecto sobre la glucocinasa.
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
TW200503674A (en) Therapeutic agents
UA83691C2 (ru) Применение замещенных 2-аминотетралинов для упреждающего лечения болезни паркинсона
MX2009002920A (es) Tratamiento del dolor, diabetes y trastornos del metabolismo de los lipidos.
WO2004045618A3 (fr) Nouveaux medicaments destines au traitement de la bronchopneumopathie chronique obstructive
BRPI0412851A (pt) benzamidazóis de n-metila-substituìdos
WO2005037798A3 (fr) Nouveaux composés
MX2008004734A (es) Composicion rica en leucina.
UA84896C2 (ru) Производные гидронопола как агонисты человеческих рецепторов orl1
NO20034504D0 (no) Erytropoietin forbedrer in vivo kjemoterapiindusert toksisitet
DK1651270T3 (da) Medikamenter til inhalation omfattende betamimetika og et anticholinergikum
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
BRPI0416188A (pt) formulações de medicamentos que contêm aromatizante, com propriedades farmacêuticas aperfeiçoadas
DE602005023840D1 (de) Azabicyclooctan-3-onderivate und deren verwendung
SE0101978D0 (sv) New compounds
NO20050398L (no) Nye adenosinanaloger og deres anvendelse som farmasoytiske midler